"This Element is an excerpt from Germs, Genes, & Civilization: How Epidemics Shaped Who We Are Today (ISBN: 9780137019960) by David P. Clark. When a virulent epidemic rages, some humans survive and some die. Before vaccination, antibiotics, and modern medical technology, what decided who was fortunate and who was not? In addition to sheer luck, both social and biological factors affect the chances of catching a disease, as well as the likelihood of surviving"--Resource description page.

This is the eBook version of the printed book. This Element is an excerpt from Germs, Genes, & Civilization: How Epidemics Shaped Who We Are Today (9780137019960) by David P. Clark. Available in print and digital formats. ¿ Why do some survive disease while others die--and how does humanity develop greater genetic resistance to infection? ¿ When a virulent epidemic rages, some humans survive and some die. Before vaccination, antibiotics, and modern medical technology, what decided who was fortunate and who was not? In addition to sheer luck, both social and biological factors affect the chances of catching a disease, as well as the likelihood of surviving. Let’s start with strictly biological factors....

Infectious diseases are commonly regarded as a distinct category, with different causes and patterns than chronic or genetic disease. But in fact there are many varieties of genetic susceptibility to infection, the subject of this book, which will be divided into three sections: 1) concepts and methods, 2) genes and pathophysiologic mechanisms, and 3) infectious agents and diseases. No currently plubished text on either genetics or infectious diseases focuses on the genetic aspects of the special relationship between host and pathogen in the way envisioned for Section 1. No other work on the selected genes regulating immunity deals as systematically with the sequence variation/function relationships most pertinent to infection as planned for Section 2. And no other book gives as meaningful a picture of how these genes operate in infectious disease as Section 3 will.

Genetics and Evolution of Infectious Diseases, Third Edition discusses the evolving field of infectious diseases and their continued impact on the health of populations, especially in resource-limited areas of the world where they must confront the dual burden of death and disability due to infectious and chronic illnesses. Although substantial gains have been made in public health interventions for the treatment, prevention, and control of infectious diseases, in recent decades the world has witnessed the emergence of the human immunodeficiency virus (HIV) and the COVID-19 pandemic, increasing antimicrobial resistance, and the emergence of many new bacterial, fungal, parasitic, and viral pathogens. Fully updated and revised, this new edition presents the consequences of such diseases, the evolution of infectious diseases, the genetics of host-pathogen relationship, and the control and prevention strategies that are, or can be, developed. This book offers valuable information to biomedical researchers, clinicians, public health practitioners, decisions-makers, and students and postgraduates studying infectious diseases, microbiology, medicine, and public health that is relevant to the control and prevention of neglected and emerging worldwide diseases. - Takes an integrated approach to infectious diseases - Provides the latest developments in the field of infectious diseases - Focuses on the contribution of evolutionary and genomic studies for the study and control of transmissible diseases - Includes updated and revised contributions from leading authorities, along with six new chapters

Genetic Control of Natural Resistance to Infection and Malignancy is a collection of papers presented at the 1980 Proceedings of an International Symposium of the Canadian Society for Immunology held in Montreal, Quebec. It provides information about the different models of genetic resistance to various diseases. The book offers an overview of the genetic determination of the susceptibility or resistance to infection and malignancy. It also discusses the importance of genetic resistance not only in the first-line observation of infections and tumors, but also in chemotherapy and immunotherapy. It then explains the genetic control of resistance to parasitic, bacterial, and virus infections, as well as to tumor growth. It further discusses the genetic control of macrophage differentiation and function.

This informative guide provides a comprehensive overview of the biology and care of immunodeficient rodents, which are essential for the study of human diseases and the development of new treatments. It is an invaluable resource for scientists, veterinarians, and animal care professionals. This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work is in the "public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.

Human population is escalating at an enormous pace and is estimated to reach 9.7 billion by 2050. As a result, there will be an increase in demand for agricultural production by 60–110% between the years 2005 and 2050 at the global level; the number will be even more drastic in the developing world. Pathogens, animals, and weeds are altogether responsible for between 20 to 40 % of global agricultural productivity decrease. As such, managing disease development in plants continues to be a major strategy to ensure adequate food supply for the world. Accordingly, both the public and private sectors are moving to harness the tools and paradigms that promise resistance against pests and diseases. While the next generation of disease resistance research is progressing, maximum disease resistance traits are expected to be polygenic in nature and controlled by selective genes positioned at putative quantitative trait loci (QTLs). It has also been realized that sources of resistance are generally found in wild relatives or cultivars of lesser agronomic significance. However, introgression of disease resistance traits into commercial crop varieties typically involves many generations of backcrossing to transmit a promising genotype. Molecular marker-assisted breeding (MAB) has been found to facilitate the pre-selection of traits even prior to their expression. To date, researchers have utilized disease resistance genes (R-genes) in different crops including cereals, pulses, and oilseeds and other economically important plants, to improve productivity. Interestingly, comparison of different R genes that empower plants to resist an array of pathogens has led to the realization that the proteins encoded by these genes have numerous features in common. The above observation therefore suggests that plants may have co-evolved signal transduction pathways to adopt resistance against a wide range of divergent pathogens. A better understanding of the molecular mechanisms necessary for pathogen identification and a thorough dissection of the cellular responses to biotic stresses will certainly open new vistas for sustainable crop disease management. This book summarizes the recent advances in molecular and genetic techniques that have been successfully applied to impart disease resistance for plants and crops. It integrates the contributions from plant scientists targeting disease resistance mechanisms using molecular, genetic, and genomic approaches. This collection therefore serves as a reference source for scientists, academicians and post graduate students interested in or are actively engaged in dissecting disease resistance in plants using advanced genetic tools.

Over the past century, we have made great strides in reducing rates of disease and enhancing people's general health. Public health measures such as sanitation, improved hygiene, and vaccines; reduced hazards in the workplace; new drugs and clinical procedures; and, more recently, a growing understanding of the human genome have each played a role in extending the duration and raising the quality of human life. But research conducted over the past few decades shows us that this progress, much of which was based on investigating one causative factor at a time—often, through a single discipline or by a narrow range of practitioners—can only go so far. Genes, Behavior, and the Social Environment examines a number of well-described gene-environment interactions, reviews the state of the science in researching such interactions, and recommends priorities not only for research itself but also for its workforce, resource, and infrastructural needs.